PLTK vs. EBS

Last updated Jun 4, 2026

PLTK (Playtika Holding Corp.) and EBS (Emergent BioSolutions Inc.) are both stocks. PLTK operates in Electronic Gaming & Multimedia (Communication Services), while EBS operates in Drug Manufacturers - Specialty & Generic (Healthcare). Over the past 5 years, PLTK returned -32.06%/yr vs -34.22%/yr for EBS. At a 0.27 correlation, their price movements are largely independent.

Performance

PLTK vs. EBS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Playtika Holding Corp. (PLTK) and Emergent BioSolutions Inc. (EBS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, PLTK achieves a -18.73% return, which is significantly higher than EBS's -35.84% return.

PLTK

• 1D: -5.03%
• 1M: -12.05%
• YTD: -18.73%
• 6M: -21.65%
• 1Y: -28.27%
• 3Y*: -28.30%
• 5Y*: -32.06%
• 10Y*: —

EBS

• 1D: -3.41%
• 1M: -7.14%
• YTD: -35.84%
• 6M: -31.64%
• 1Y: 23.71%
• 3Y*: -1.27%
• 5Y*: -34.22%
• 10Y*: -15.21%

*Multi-year figures are annualized to reflect compound growth (CAGR)

PLTK vs. EBS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
PLTK Playtika Holding Corp.	-18.73%	-37.16%	-16.05%	2.47%	-50.78%	-45.32%
EBS Emergent BioSolutions Inc.	-35.84%	29.29%	298.33%	-79.68%	-72.83%	-59.10%

Correlation

The correlation between PLTK and EBS is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (3Y) Calculated over the trailing 3-year period	0.26
Correlation (5Y) Calculated over the trailing 5-year period	0.28
Correlation (All Time) Calculated using the full available price history since Jan 19, 2021	0.27

Fundamentals

EPS PLTK : -$0.79 EBS : -$0.37
PS Ratio PLTK : 0.43 EBS : 0.49
Total Revenue (TTM) PLTK : $2.79B EBS : $676.80M
Gross Profit (TTM) PLTK : $2.04B EBS : $292.40M
EBITDA (TTM) PLTK : $144.30M EBS : $126.60M

Return for Risk

PLTK vs. EBS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PLTK

PLTK Risk / Return Rank: 17
PLTK Sharpe Ratio Rank: 17
PLTK Sortino Ratio Rank: 17
PLTK Omega Ratio Rank: 19
PLTK Calmar Ratio Rank: 16
PLTK Martin Ratio Rank: 15

EBS

EBS Risk / Return Rank: 54
EBS Sharpe Ratio Rank: 51
EBS Sortino Ratio Rank: 56
EBS Omega Ratio Rank: 57
EBS Calmar Ratio Rank: 53
EBS Martin Ratio Rank: 52

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PLTK vs. EBS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Playtika Holding Corp. (PLTK) and Emergent BioSolutions Inc. (EBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	PLTK	EBS	Difference
Sharpe ratio Return per unit of total volatility	-0.56	0.29	-0.85
Sortino ratio Return per unit of downside risk	-0.59	1.11	-1.70
Omega ratio Gain probability vs. loss probability	0.93	1.15	-0.22
Calmar ratio Return relative to maximum drawdown	-0.67	0.55	-1.21
Martin ratio Return relative to average drawdown	-1.17	1.03	-2.19
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

PLTK vs. EBS - Sharpe Ratio Comparison

The current PLTK Sharpe Ratio is -0.56, which is lower than the EBS Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of PLTK and EBS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	PLTK	EBS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.56	0.29	-0.85
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.63	-0.34	-0.30
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.19	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.66	-0.03	-0.63

Drawdowns

PLTK vs. EBS - Drawdown Comparison

The maximum PLTK drawdown since its inception was -90.76%, smaller than the maximum EBS drawdown of -98.89%. Use the drawdown chart below to compare losses from any high point for PLTK and EBS.

Drawdown Indicators

	PLTK	EBS	Difference
Max Drawdown Largest peak-to-trough decline	-90.76%	-98.89%	+8.13%
Max Drawdown (1Y) Largest decline over 1 year	-42.58%	-43.53%	+0.95%
Max Drawdown (3Y) Largest decline over 3 years	-75.12%	-84.58%	+9.46%
Max Drawdown (5Y) Largest decline over 5 years	-89.33%	-97.73%	+8.40%
Max Drawdown (10Y) Largest decline over 10 years	—	-98.89%	—
Current Drawdown Current decline from peak	-89.10%	-94.12%	+5.02%
Average Drawdown Average peak-to-trough decline	-65.88%	-41.07%	-24.81%
Ulcer Index Depth and duration of drawdowns from previous peaks	24.30%	23.11%	+1.19%

Volatility

PLTK vs. EBS - Volatility Comparison

The current volatility for Playtika Holding Corp. (PLTK) is 15.68%, while Emergent BioSolutions Inc. (EBS) has a volatility of 17.24%. This indicates that PLTK experiences smaller price fluctuations and is considered to be less risky than EBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	PLTK	EBS	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.68%	17.24%	-1.56%
Volatility (6M) Calculated over the trailing 6-month period	38.92%	47.98%	-9.06%
Volatility (1Y) Calculated over the trailing 1-year period	50.64%	82.42%	-31.78%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	50.76%	102.17%	-51.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	50.12%	79.95%	-29.83%

Dividends

PLTK vs. EBS - Dividend Comparison

PLTK's dividend yield for the trailing twelve months is around 9.35%, while EBS has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
EBS Emergent BioSolutions Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	5.65%
PLTK Playtika Holding Corp.	9.35%	10.13%	5.76%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

PLTK vs. EBS - Profitability Comparison

The chart below illustrates the profitability comparison between Playtika Holding Corp. and Emergent BioSolutions Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

PLTK - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Playtika Holding Corp. reported a gross profit of 552.50M and revenue of 744.70M. Therefore, the gross margin over that period was 74.2%.

EBS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Emergent BioSolutions Inc. reported a gross profit of 61.20M and revenue of 156.10M. Therefore, the gross margin over that period was 39.2%.

PLTK - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Playtika Holding Corp. reported an operating income of -49.60M and revenue of 744.70M, resulting in an operating margin of -6.7%.

EBS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Emergent BioSolutions Inc. reported an operating income of 0.00 and revenue of 156.10M, resulting in an operating margin of 0.0%.

PLTK - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Playtika Holding Corp. reported a net income of -57.50M and revenue of 744.70M, resulting in a net margin of -7.7%.

EBS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Emergent BioSolutions Inc. reported a net income of 0.00 and revenue of 156.10M, resulting in a net margin of 0.0%.

Frequently Asked Questions

Can I hold both PLTK and EBS in my portfolio?

PLTK and EBS have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, PLTK or EBS?

EBS has higher volatility (17.24%) compared to PLTK (15.68%). In terms of maximum drawdown, PLTK dropped -90.76% vs EBS's -98.89%.

Which has better risk-adjusted returns?

EBS currently has the higher Sharpe Ratio (0.29 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.